Results 221 to 230 of about 4,089,631 (323)

Geographical distribution and the impact of socio-environmental indicators on incidence of Mpox in Ontario, Canada. [PDF]

PLoS One
Ugwu CLJ, Asgary A, Wu J, Kong JD, Bragazzi NL, Orbinski J, Woldegerima WA.   +6 more
europepmc   +1 more source

Gestion inter-organisationnelle des connaissances et gestion des chaînes logistiques : enjeux, limites et défis

, 2009
Nathalie Fabbe-costes, Agnès Lancini
semanticscholar   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Embolie pulmonaire à risque intermédiaire–élevé chez une femme de 53 ans présentant un cancer colorectal et une contre-indication à la thrombolyse. [PDF]

CMAJ
Hanson NL, Utgikar R, Bokhari M, Tan KT.
europepmc   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Reversal of Left Bundle Branch Block Following Treatment in Alcoholic Cardiomyopathy. [PDF]

Arq Bras Cardiol
Barroso MCRD, Madogolele HDCN, Belfort DSP, Biselli B, Ayub-Ferreira SM, Bocchi EA.   +5 more
europepmc   +1 more source

Abortion limits [PDF]

Nature, 1990
openaire   +2 more sources

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Hyponatremia and the risk of Osmotic Demyelination Syndrome: is it time to review sodium correction rates? [PDF]

J Bras Nefrol
Gomes CP.
europepmc   +1 more source

The Limitation of Limitations

Structural Heart
openaire   +2 more sources